Find Publications

Search concepts
Selected Filters
2018
3 Citations (Scopus)

A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma

Gbolahan, O. B., Porter, R. F., Salter, J. T., Yiannoutsos, C., Burns, M., Chiorean, E. G. & Loehrer, P., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Pemetrexed
Thymoma
Folic Acid Antagonists
2016

NUT Midline carcinoma masquerading as a thymic carcinoma

Polar, Y., Kesler, K., Loehrer, P. & Badve, S., May 10 2016, In : Journal of Clinical Oncology. 34, 14, p. e126-e129

Research output: Contribution to journalArticle

Thymoma
Carcinoma
2018
2 Citations (Scopus)

Randomized phase IIA trial of gemcitabine compared with bleomycin plus vincristine for treatment of Kaposi's sarcoma in patients on combination antiretroviral therapy in western Kenya

Busakhala, N. W., Waako, P. J., Strother, M. R., Keter, A. K., Kigen, G. K., Asirwa, F. C. & Loehrer, P., Mar 1 2018, In : Journal of global oncology. 2018, 4

Research output: Contribution to journalArticle

gemcitabine
Kaposi's Sarcoma
Kenya
Bleomycin
Vincristine
1 Citation (Scopus)
Polymyositis
Thymoma
Myasthenia Gravis
Myocarditis
Giant Cells
2019

Detection and Concentration of Plasma Aflatoxin Is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women

Zhang, J., Orang'O, O., Tonui, P., Tong, Y., Maina, T., Kiptoo, S., Muthoka, K., Groopman, J., Smith, J., Madeen, E., Ermel, A., Loehrer, P. & Brown, D. R., Oct 5 2019, In : Open Forum Infectious Diseases. 6, 9, ofz354.

Research output: Contribution to journalArticle

Open Access
Aflatoxins
Aflatoxin B1
Lysine
Uterine Cervical Neoplasms
Uterine Cervical Dysplasia
2018
4 Citations (Scopus)

The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts

Morgan, C., Cira, M., Karagu, A., Asirwa, F. C., Brand, N. R., Buchanan Lunsford, N., Dawsey, S. M., Galassi, A., Korir, A., Kupfer, L., Loehrer, P. J., Makumi, D., Muchiri, L., Sayed, S., Topazian, H., Welch, J., Williams, M. J. & Duncan, K., Sep 2018, In : Journal of Cancer Policy. 17, p. 38-44 7 p.

Research output: Contribution to journalArticle

Kenya
Research
Neoplasms
Registries
International Agencies

Neoplasms of the mediastinum

Cameron, R. B., Loehrer, P., Marx, A. & Lee, P. P., Nov 16 2018, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Wolters Kluwer Health Pharma Solutions (Europe) Ltd, p. 701-712 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mediastinal Neoplasms
2019

Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya

Busakhala, N., Kigen, G., Waako, P., Strother, R. M., Chite, F. & Loehrer, P., Sep 10 2019, In : Infectious Agents and Cancer. 14, 1, 24.

Research output: Contribution to journalArticle

Open Access
Kaposi's Sarcoma
Kenya
Combination Drug Therapy
Teaching Hospitals
Referral and Consultation
2016
11 Citations (Scopus)

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

Radovich, M., Solzak, J. P., Hancock, B. A., Conces, M. L., Atale, R., Porter, R. F., Zhu, J., Glasscock, J., Kesler, K., Badve, S., Schneider, B. & Loehrer, P., Jan 14 2016, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

Chromosomes, Human, Pair 19
Thymoma
MicroRNAs
Phosphatidylinositol 3-Kinases
Neoplasms
2019

Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies

Hellyer, J. A., Gubens, M. A., Cunanan, K. M., Padda, S. K., Burns, M., Spittler, A. J., Riess, J. W., San Pedro-Salcedo, M., Ramchandran, K. J., Neal, J. W., Wakelee, H. A. & Loehrer, P. J., Nov 2019, In : Lung Cancer. 137, p. 71-75 5 p.

Research output: Contribution to journalArticle

Thymoma
Neoplasms
Febrile Neutropenia
amrubicin
Topoisomerase II Inhibitors
2016
34 Citations (Scopus)

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L., Cheng, L., Nassiri, M., Davidson, D., Rushing, D. A., Loehrer, P., Pili, R., Hanna, N., Thomas Callaghan, J., Skaar, T., Helft, P., Shahda, S. & 2 others, O'Neil, B. H. & Schneider, B., 2016, In : Oncotarget. 7, 35, p. 56491-56500 10 p.

Research output: Contribution to journalArticle

Precision Medicine
Disease-Free Survival
Neoplasms
Therapeutics
Standard of Care
2018
25 Citations (Scopus)

The Integrated Genomic Landscape of Thymic Epithelial Tumors

The Cancer Genome Atlas Network, Feb 12 2018, In : Cancer Cell. 33, 2, p. 244-258.e10

Research output: Contribution to journalArticle

Thymoma
Myasthenia Gravis
Autoantigens
Aneuploidy
Mutation
2019

A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women

Ermel, A., Tonui, P., Titus, M., Tong, Y., Wong, N., Ong'echa, J., Muthoka, K., Kiptoo, S., Moormann, A., Hogan, J., Mwangi, A., Cu-Uvin, S., Loehrer, P., Orang'o, O. & Brown, D., Apr 27 2019, In : BMC Infectious Diseases. 19, 1, 352.

Research output: Contribution to journalArticle

Open Access
Cross-Sectional Studies
HIV
Sexual Partners
Human papillomavirus 16
Demography
2017
1 Citation (Scopus)

Adjuvant gemcitabine and gemcitabine-based chemoradiotherapy versus gemcitabine alone after pancreatic cancer resection the Indiana University experience

Khawaja, M. R., Kleyman, S., Yu, Z., Howard, T., Burns, M., Nakeeb, A., Loehrer, P. J., Cardenes, H. R. & Chiorean, E. G., Jan 1 2017, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 1, p. 42-46 5 p.

Research output: Contribution to journalArticle

gemcitabine
Chemoradiotherapy
Pancreatic Neoplasms
Drug Therapy
Survival
2019
1 Citation (Scopus)

Global Oncology

Gopal, S. & Loehrer, P. J., Jan 1 2019, In : JAMA - Journal of the American Medical Association.

Research output: Contribution to journalReview article

2016
3 Citations (Scopus)

Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

Research output: Contribution to journalArticle

Inpatients
Hepatocellular Carcinoma
Immunologic Factors
Bilirubin
Survival
10 Citations (Scopus)

Medical education and training: Building in-country capacity at all levels

Asirwa, F. C., Greist, A., Busakhala, N., Rosen, B. & Loehrer, P., Jan 1 2016, In : Journal of Clinical Oncology. 34, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

Medical Education
Neoplasms
Education
Health Services Accessibility
Public Hospitals
2018
11 Citations (Scopus)
Trifluridine
Colorectal Neoplasms
Patient Care
Placebos
European Union